Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Resmed Inc’s Director, Peter Farrell, is set to sell 2,000 shares of common stock with an estimated market value of $500,000 on the NYSE. This move comes after Farrell’s recent sales totaling 4,000 shares over the past few months, reflecting his ongoing strategy to manage his stock holdings. Investors may want to watch how these transactions impact Resmed’s stock performance in the coming months.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
